All In MedTech

FDA Clearance Tracker · K192302

Mahurkar Acute Single Lumen Catheter, Mahurkar Acute Dual Lumen Catheter, Mahurkar Acute Triple Lumen Catheter, Mahurkar Acute High Pressure Triple Lumen Catheter

A 510(k) clearance means FDA found the device substantially equivalent to one already on the market. It is not an approval, and it is not a finding that the device works better than others.

Last checked: Nov 19, 2026Latest source record: Jan 17, 2020 (this decision)Source: openFDAMethods & limitations

510(k)

Decided

Jan 17, 2020

Unknown

Time to decision

147 days

Received Aug 23, 2019. Calendar days, including time FDA spent waiting on the applicant.

Pathway

510(k)

Traditional

Device class

Class II

The decision

FDA number
K192302
Device name
Mahurkar Acute Single Lumen Catheter, Mahurkar Acute Dual Lumen Catheter, Mahurkar Acute Triple Lumen Catheter, Mahurkar Acute High Pressure Triple Lumen Catheter
Applicant
Covidien, LLC
Applicant location
Mansfield, MA
Received
Aug 23, 2019
Decided
Jan 17, 2020
Decision
Unknown
Submission type
Traditional

Device type

Device class
Class II
Regulation
21 CFR 876.5540

Every decision under product code MPB

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code MPB. The earliest in FDA's data is K871360, decided Apr 29, 1987.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.

Other decisions for Covidien, LLC

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.